Top 10 Books about Stock Investing to read in 2018. Read more.

EDGE - Edge Therapeutics

Exchange: NASDAQ

EDGE - Edge Therapeutics

Exchange: NASDAQ

Thu 22'nd Mar 2018

PERIOD 2017-12-26 - 2018-03-22
CHANGE -1.49%
PRICE $16.49





Request Prediction

Edge Therapeutics Stock Analysis

Technical stock analysis for Thu 22'nd Mar 2018

Buy candidate since 2018-03-21 Loss -1.49%

Edge Therapeutics fell by -1.49% in the last day from $16.74 to $16.49 The price has been going up and down for this period, and there has been a 0.37% gain for the last 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -128 918 shares and in total 78 061 shares bought and sold for approximately $1.29 million.

Shorts 7.48% ( 2018-02-28 )
Cash 301.6 mill
Loans 55.6 mill
Beta 2.01
ROA -46.42


Edge Therapeutics lies in the lower part of a wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $16.14 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 74.02% during the next 3 months and, with 90% probability hold a price between $28.08 and $32.26 at the end of this period.

Click here for today's Top 5 Trending Companies


Edge Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $16.45 and $15.09. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Friday March 16, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 59 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Edge Therapeutics finds support from accumulated volume at $16.47. On the upside the stock meets some resistance just above today's level from accumulated volume at $16.74, $16.91 and $17.20.

The stock is about to test the resistance from accumulated volume at $16.74 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $16.47 Price: $16.49 Resistance: $16.74


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.57 between high and low, or 3.51%. For the last week the stock has had a daily average volatility of 5.96%.

Our recommended stoploss: $15.64 (-5.15%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 4 days ago.)

Overall risk:

Very Low Low Medium High Very High


Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Trade EDGE CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features